PCPA Testifies at National Parity Hearing in Philadelphia

February 27, 2007

Good morning. My name is Alan Hartl. I am Executive Director of Lenape Valley Foundation located in Doylestown, Pennsylvania. Lenape Valley Foundation provides mental health, mental retardation, and early intervention services to children and adults.

First, I would like to thank Congressmen Patrick Kennedy (D-RI) and Jim Ramstad (R-MN) for their leadership in crafting legislation calling for parity regarding insurance coverage of mental health and substance abuse problems and for their willingness to hold nationwide forums. I would also like to thank Congressman Sestak, who happens to be my Congressman, for hosting one of the two Pennsylvania forums. Also, thank you to the Mental Health Association for organizing this event and to Elwyn for serving as the host site.

Today, besides Lenape Valley Foundation, I also represent the Pennsylvania Community Providers Association (commonly known as PCPA). I currently serve as PCPA’s Legislative Affairs Committee Co-Chair. PCPA represents over 200 community-based providers of mental health, mental retardation, substance abuse, and other human services. Our host today, Elwyn, is one of PCPA’s members. Our members provide services in over 1,100 locations throughout Pennsylvania’s 67 counties. As the premier Pennsylvania association with members who provide both mental health and substance abuse services, PCPA is in a unique position to comment on the legislation in question.

This legislation is important because treatment for mental health and substance abuse issues works. One need only speak to some of the very people here today – consumers and families - to confirm this. All Americans must be afforded the opportunity to seek such treatment when the need arises. The 1999 Surgeon General’s Report on Mental Health and the 2003 President’s New Freedom Commission on Mental Health both make this point. These reports further state that such conditions must be treated with the same urgency and status as physical health problems. Assuring that health insurance plans recognize this and provide coverage in a manner equitable to other health conditions is a significant step forward in improving the overall health of our citizens.

If you have any doubts concerning this, consider the following:

Despite the overwhelming evidence of the cost and profound deleterious impact of not treating behavioral health disorders, the very need for this legislation points to the history of health care plans not including equitable coverage to their subscribers. Federal legislation is needed if this is to be reversed. If protections are imposed to assure behavioral health treatment, great things can be accomplished as evidenced by the unparalleled success of Pennsylvania’s carve-out of Medicaid behavioral health services in its HealthChoices program. These protections should not be limited to certain diagnoses, but rather should encompass all behavioral health diagnoses contained within the current Diagnostic and Statistical Manual. The brain-body connection is well-established, and an array of effective treatments is available. Anyone who can benefit from treatment should not be denied because their diagnosis is not one of a select few. Similarly, a health plan should be expected to provide coverage for treatment of a diagnosable behavioral health disorder that is disrupting the life of one of its members.

It is important that this federal legislation be enacted now. Various states, including Pennsylvania, are considering universal health care proposals. Without federal legislation setting a minimum standard for parity in the treatment of mental health and substance abuse disorders, states may be tempted to emulate the policies of commercial plans that severely limit such coverage. The federal government has the responsibility to assure that all its citizens have vital services protected, such as healthcare, regardless of where someone might live.

Simultaneously, federal legislation need only establish a floor and should not pre-empt state legislation that provides greater protection of coverage for behavioral health disorders. Such is the case with Pennsylvania's Act 106 for drug and alcohol treatment under commercial insurance, which is not clearly protected in Senate Bill 558, a parity bill which is now being considered by the U.S. Senate. I do not believe that is your intention, but we must be sure to protect such state laws - both by making sure language in the House Bill reflects this and having it inserted in the current Senate companion bill.

The 1999 Surgeon General’s report established that mental health is fundamental to health and that "treatment and mental health services are critical to the nation’s health. . . [and] have an immense impact on individuals and families throughout this nation and the world." Given this, it is time that we make sure that such services are one of our health priorities, and not afforded second class or, worse, no coverage.

Thank you for your time today and allowing me to testify. George Kimes, PCPA's Executive Director, will testify at the March 12 Pittsburgh hearing. At that time, PCPA will submit additional comprehensive written testimony for your consideration.

Citations corresponding to bullets in the testimony of Alan J. Hartl, MS:

1. US Department of Health and Human Services. Mental Health: A Report of the Surgeon General, Rockville, MD: US Department of Helath and Human Services, Substance Abuse and Mental Helath Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, 1999.

2. The President’s New Freedom Commission on Mental Health. Achieving the Promise: Transforming Mental Health Care in Americy, Rockville, MD, 2003.

3. Rydell, C.P. & Everingham, S.S. (1994) Controlling Cocaine Supply Versus Demand Programs. RAND Drug Policy Research Center. Santa Monica, CA.

4. State of California (1994). Evaluating Recovery Services: The California Drug and Alcohol Treatment Assessment (CALDATA), Exec Summary, (ADP) 94-4628. Retrieved May 13, 2003 from http://www.adp.cahwnet.gov/RC/pdf/caldata.pdf

5. Holder, H. (1998). Cost Benefits of Substance Abuse Treatment: An Overview of Results from Alcohol and Drug Abuse. The Journal of Mental Health Policy and Economics, 1, 23-29.

Back